Narvs Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.60 M
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth 6.54%
- Profit Growth 107.00%
- Ebitda -8.09%
- Net Worth 2.83%
- Total Assets 8.70%
About Narvs Pharma
Narvs Pharma Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 February 2015 (Nine years and 11 months 12 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹1.00 M.
Navneet Kumar, Babli Kumari, and Kanchan Soni serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900DL2015PTC277334
-
Company No.
277334
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Feb 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Narvs Pharma Private Limited offer?
Narvs Pharma Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Common Disease Medicines, Eye Drops, Ayurvedic & Herbal Extracts, Fruit Extracts, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Antifungal Injection, Tablet & Syrup, Ayurvedic,Herbal Products & Medicine.
Who are the key members and board of directors at Narvs Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Navneet Kumar
|
Director | 25-Mar-2022 | Current |
|
Babli Kumari
|
Director | 25-Mar-2022 | Current |
|
Kanchan Soni
|
Director | 25-Mar-2022 | Current |
Financial Performance of Narvs Pharma.
Narvs Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 6.54% increase. The company also saw a substantial improvement in profitability, with a 107% increase in profit. The company's net worth moved up by a moderate rise of 2.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Narvs Pharma?
In 2017, Narvs Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Nskin Pharma Private LimitedNavneet Kumar and Kanchan Soni are mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Mar 2016 | Others | ₹1.00 M | Open |
How Many Employees Work at Narvs Pharma?
Unlock and access historical data on people associated with Narvs Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Narvs Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Narvs Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
